Mesoblast Reports Financial Results and Corporate Highlights for First Half Ended December 31, 2019

    NEXT STORY
    ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
    PREV STORY
    Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VAXIL CHANGES WEBSITE DOMAIN NAME, PROVIDES UPDATE ON THE EXERCISE OF WARRANTS AND RECEIVES FINAL TSXV EXCHANGE APPROVAL ON THE DEBENTURE FINANCINGS

    author_avatar
    NASDAQ Market News

    BeiGene Announces Presentations at the European Society for Medical Oncology 2017 Congress

    CAMBRIDGE, Mass. and BEIJING, China, Aug. 30, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

    author_avatar
    NASDAQ Market News

    Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016

    SAN RAMON, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

    author_avatar
    NASDAQ Market News